Form 4: Curis Inc. Director Granted Stock Options
Statement of Changes in Beneficial Ownership
Curis Inc. Director Marc Rubin was granted 6,800 stock options with an exercise price of $5.29, vesting fully on July 7, 2027.
Summary
- Marc Rubin, a Director at Curis Inc., was granted 6,800 non-qualified stock options on July 7, 2026.
- The exercise price for these options is $5.29 per share.
- The options will vest 100% on July 7, 2027.
- These options are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details a routine stock option grant to a director, which is a standard compensation practice and does not inherently signal positive or negative company performance.
Positives
- Grant of stock options to a Director can align management incentives with shareholder value.
- The grant of 6,800 options provides a potential upside for the Director based on future stock performance.
Negatives
- The filing does not contain any negative financial or operational information.
Risks
- The value of the stock options is contingent on the future performance of Curis Inc.'s stock price.
- If the stock price does not exceed the exercise price of $5.29, the options may not be exercised profitably.
Future Outlook
The filing itself does not provide a future outlook for the company. The stock options granted have an expiration date of July 6, 2036, and vest fully on July 7, 2027, indicating a long-term incentive structure.
Management Comments
- Marc Rubin, as a Director, has been granted stock options, indicating a form of executive compensation and incentive alignment.
Industry Context
StockSavvy.ai notes that the grant of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, like Curis Inc., to incentivize long-term performance and align executive interests with shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Marc Rubin has granted a Power of Attorney to specific individuals to execute Forms 3, 4, and 5 on his behalf. | 04/24/2026 | Ensures timely and accurate filing of beneficial ownership reports, facilitating compliance with SEC regulations. |
Stakeholder Impact
- Shareholders: The stock option grant aligns director incentives with potential future stock price appreciation, which can benefit shareholders if the company performs well.
- Management: Provides a financial incentive for the director to contribute to the company's success.
Next Steps
- Marc Rubin may exercise his stock options on or after July 7, 2027, provided the stock price is above the exercise price of $5.29.
- The company will continue to file Section 16 reports for any future transactions by its officers and directors.
Key Dates
| Date | Description |
|---|---|
| 04/24/2026 | Date of execution of Power of Attorney by Marc Rubin. |
| 07/06/2026 | Deemed execution date for the transaction. |
| 07/07/2026 | Transaction date for the grant of stock options. |
| 07/07/2027 | Vesting date for 100% of the granted stock options. |
| 07/06/2036 | Expiration date of the stock options. |
| 07/09/2026 | Date of filing of the Form 4. |
Keywords
Curis Inc., CRIS, Form 4, Stock Options, Director, SEC Filing, Beneficial Ownership, Marc Rubin, Rule 10b5-1(c)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.